Bone Marrow Cellularity at Day 14 Is the Most Important Predictive Factor for Response in Patients With AML Who Require Double-Induction Chemotherapy: Analysis From a Large, Single Institution Experience

American Journal of Hematology - United States
doi 10.1002/ajh.24627
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Bevacizumab and Chemotherapy for Recurrent Glioblastoma: A Single-Institution Experience

Neurology
Neurology
2009English

Experience on the Sister Who Became a Bone Marrow Donor at Her Childhood

Kitakanto Medical Journal
Medicine
2009English

Unrelated Donor Bone Marrow Transplantation for 100 Pediatric Patients: A Single Institute's Experience

Bone Marrow Transplantation
TransplantationHematology
2005English

Genomic Profiling for Patients With Solid Tumors: A Single-Institution Experience

Annals of Clinical Oncology
2019English

Day 14 Bone Marrow Examination in the Management of Acute Myeloid Leukemia

American Journal of Hematology
Hematology
2017English

Bone Marrow Transplantation for CD40 Ligand Deficiency: A Single Centre Experience

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2001English

Bone Marrow Microenvironment in the Pathogenesis of AML

2011English

Bone Involvement in Patients With Cervical Carcinoma: A Single-Institution Cohort Study

Southern African Journal of Gynaecological Oncology
2019English

Efficacy and Safety of Chemotherapy After Endoscopic Double Stenting for Malignant Duodenal and Biliary Obstructions in Patients With Advanced Pancreatic Cancer: A Single-Institution Retrospective Analysis

BMC Gastroenterology
MedicineGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy